共查询到20条相似文献,搜索用时 125 毫秒
1.
为了寻找抗生育药物,从17β-羟基-7α-甲基-4-雌烯-3-酮经17β-羟基-7α-甲基-4β,5β-环氧雌烷-3-酮合成了七个4-位取代的目标化合物:4,17β-二羟基-7α-甲基-4-雌烯-3-酮及其17-乙酸酯、4-甲氧基-17β-羟基-7α-甲基-4-雌烯-3-酮及其17-乙酸酯、4-氯-17β-羟基-7α-甲基-4-雌烯-3-酮及其17-乙酸酯和4-溴-17β-羟基-7α-甲基-4-雌烯-3-酮。这些化合物均可竞争性地与人蜕膜孕酮受体结合,并能抑制蜕膜细胞的发育,对大鼠具有显著的抗着床活性。 相似文献
2.
3.
以18-甲基-17β-羟基-17α-乙炔基-雌甾-4-烯-3-酮(18-甲基炔诺酮),17β-羟基-17α-乙缺基-雌甾-4-烯-3-酮(炔诺酮),17β-羟基-17α-乙炔基-雄甾-4-烯-3-酮(妊娠素)和17a-羟基孕甾-4-烯-3,20二酮(17α-羟基黄体酮)为原料,经NaBH,还原、脱水、双键转位和酯化等反应合成一系列3,5-甾二烯化合物,用1HNMR和MS证明了它们的结构。动物筛选结果表明,17β-丙酰氧基-17α-乙炔基-雌甾-3,5-二烯(IVb2有明显的抗早孕活性。中断早期妊娠的作用似与其雌激素活性有关。 相似文献
4.
5.
本工作表明17β-羟-7α-甲-5-雄烯-3-酮在妊娠小鼠、大鼠均有抗早孕和抗着床作用。在小鼠,17β-羟-7α-甲-5-雄烯-3-酮抗早孕作用的ED_(50)=0.159±0.055mg/kg。17β-羟-7α-甲-5-雄烯-3-酮在抗早孕剂量时能明显抑制假孕小鼠的蜕膜反应。甲地孕酮能完全对抗其抗早孕作用,也能完全对抗其抑制蜕膜反应的作用。早孕大鼠皮下注射17β-羟-7α-甲-5-雄烯-3-酮24小时后血浆孕酮浓度已明显下降。以上结果提示17β-羟-7α-甲-5-雄烯-3-酮抗早孕作用可能与其抑制孕酮合成有关。此外,本文对17β-羟-7α-甲-5-雄烯-3-酮的雌素活性和孕激素活性也进行了观察。 相似文献
6.
为了寻找心血管系统药物,以表雄酮为原料,合成了7个16,17位取代的目标化合物:2β-(4’-甲基-1’-哌嗪基)-3α-羟基-5α-雄甾-17-酮、2β-(4’-甲基-1’-哌嗪基)-3α,17β-二羟基-5α-雄甾烷、2β-(4’-甲基-1’-哌嗪基)-3α-羟基-16α-溴-5α-雄甾-17-酮、2β-(4’-甲基-1’-哌嗪基)-3α,16α-二羟基-17-氧-5α-雄甾烷、2β-(4’-甲基-1’-哌嗪基)-3α,16α-二羟基-17-肟-5α-雄甾烷、2β-(4’-甲基-1’-哌嗪基)-3α,16α-二羟基-17β-氨基-5α-雄甾烷和2β—(4’-甲基-1’-哌嗪基)-3α,17β-二羟基-16β-氨基-5α-雄甾烷。初步药理试验结果表明它们都有不同程度的抗心律失常活性。 相似文献
7.
8.
用诺卡氏菌与节杆菌混合菌种转化从蕃麻皂素制得的中间体5α-△~((?)(11))-16β-甲基-3β,17α,21三羟基孕甾烯-3β,21-双醋酸酯-20酮(Ⅰ)得50%的16β-甲基-△~(1,4,9(11))-孕甾三烯-20酮(Ⅱ)和少量的16β-甲基-9,11α环氧-△~1,4孕甾二烯-20酮(Ⅲ)。另外,又用同样的混合菌种转化从剑麻皂素制得的中间体5α,17α甲基-17β羟基-雄甾-3酮(Ⅳ)得50%17α甲基-17β羟基-△~(1,4)-雄甾二烯-3酮(Ⅴ)。如改变培养基则得3,17β-羟基-17α-甲基-9酮基-9,10开环-1,3,5(10)雄甾三烯化合物。 相似文献
9.
报道新化合物A-失碳-17β-羟基-17α-乙炔基-Δ3(5),9(10)-雌甾二烯-2-酮2的合成。文中探讨了用炔钾粗品对A-失碳-Δ3(5),9(10)-雌甾二烯-2,17-二酮1和A-失碳-6β,19-环氧-Δ3-雄甾-2,17-二酮3的选择性炔化,分别得标题化合物2(44%)及A-失碳-17β-羟基-17α-乙炔基-6β,19-环氧-Δ3雄甾-2-酮4(65%),4经还原性破开环氧、去羟甲基和去醋酰氧基合成了标题化合物2。四步总收率为34%。 相似文献
10.
吴如金 《国外医学(药学分册)》1976,(2)
鉴于甲雄甾烯诺龙[Methandrostenolone,去氢甲基睾丸素,即17β-羟基-17α甲基-甲基雄甾-1,4-二烯-3酮,(Ⅰ)]由化学或微生物合成过程中常含有与母体化合物相关的杂质[甲基睾丸素即17-β-羟基-17a-甲基雄甾一4一烯-3-酮,(Ⅱ);6d、17B-~-羟基17α-甲基雄甾-1,4-二烯-3-酮,(Ⅲ)和6β,17β-二羟基-17α-甲基雄甾-1,4-二烯-3酮,(Ⅳ)],致使现行的药典方法(英国药典及美国副药典所载多 相似文献
11.
A L Johnson 《Journal of medicinal chemistry》1972,15(8):854-855
The synthesis of analogs of 6,6-difluoronorethindrone (la) is reported. The new compounds, each of which are potent oral progestational agents, are ( )-6,6-difluoronorgestrel (lb), 17 beta-hydroxy-6,6-difluoro-17alpha-propadienyl-4-estren-3-one (lc), 17beta-hydroxy-6,6-difluoro-17alpha-(1-propynyl)-4-estren-3-one (ld), and 17 beta-hydroxy-6,6-difluoro-17alpha-(3,3,3-trifluoropropynyl)-4-estren-3-o ne (le). The 6,6-gem-difluoro group is an important means for enhancing the progestational activity of parent compounds. Compounds lc,ld, and le were prepared from a common precursor, 6,6-difluoro-4-estrene-3,17-dione 3-ethylene ketal. The findings indicate that 6,6-difluoro steroids are stable towards a variety of reagents. The experimental procedures are summarized. 相似文献
12.
Colombo D Ferraboschi P Franchini L Nishino H Takayasu J Tokuda H 《Arzneimittel-Forschung》2008,58(2):86-90
The aim of this study was to evaluate the cancer chemopreventive potential of the widely prescribed drug tibolone (17alpha-ethynyl-7alpha-methyl-5(10)-estren-3-one, CAS 5630-53-5) and its main metabolites, 17alpha-ethynyl-7alpha-methyl-4-estren-3-one (CAS 1162-60-3), 17alpha-ethynyl-7alpha-methyl-5(10)-estrene-3alpha,17beta-diol (CAS 100239-44-9) and 17alpha-ethynyl-7alpha-methyl-5(10)-estrene-3beta,17beta-diol (CAS 100239-45-0), by studying their anti-tumor-promoting activity. To this aim the test compounds were submitted to the short term in vitro assay for the inhibition of Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) as a primary screening for anti-tumor promoters. All the compounds showed high inhibitory activity and low cytotoxicity as compared to literature data. To extend the study to an animal model, tibolone and its 3alpha-hydroxy metabolite (CAS 100239-44-9) were also assayed in the in vivo two-stage on mouse skin carcinogenesis test, exhibiting significant inhibitory effects on TPA promoted mouse skin papillomas formation. A comparison with literature data indicated them as more potent compounds than other steroids previously studied such as digitoxigenin, cortisone, hydrocortisone, and prednisolone. 相似文献
13.
7α-和7β-甲基-10β,17β-二乙酰氧基-△4-雌甾烯-3酮(简称7α-和7β-甲-乙氧雌酮)对小鼠抗早孕ED50分别为1.6和5.5 mg/kg。7α-甲-乙氧雌酮在大鼠也有抗早孕作用并使血浆孕酮浓度降低,应用10 μg/ml浓度能抑制离体妊娠大鼠卵巢孕酮合成。7α-和7β-甲-乙氧雌酮与兔子宫胞浆雌二醇受体的相对结合亲和力(RBA)分别为10.8和1.5,与孕酮受体的RBA均<1.7α-和7β-甲-乙氧雌酮都有较弱的雌激素和抗雌激素活性。 相似文献
14.
The topical anti-androgen 17 beta-hydroxy-1 alpha-methyl-17 alpha-propyl-5 alpha-androstan-3-one is determined in plasma samples by extracting with ether and subsequent mass fragmentography with single-ion detection at m/z 303. 17 beta-Hydroxy-1 alpha-methyl-17 alpha-pentyl-5 alpha-androstan-3-one, added to the samples before extraction, is used as the internal standard. Reproducibility was calculated to be +/- 5.9% at the 5-ng/mL level and 0.4% at the 20-ng/mL level. The limit of detection is approximately 1 ng/mL. Total gas chromatography-mass spectrometry analysis time is approximately 10 min/sample. 相似文献
15.
Steroid 9alpha-hydroxylase is a key enzyme system in steroid nucleus degradation in company with Delta(1)-dehydrogenase. To examine 9alpha-hydroxylase activity during microbial transformation of steroids, 9(11)-dehydro-17alpha-methyl-testosterone was adopted as a stable substrate for preventing the rupture of steroid nucleus. UsingNocardia restrictus ATCC 14887 capable of introducing a 9alpha-hydroxyl group into steroids, 9alpha, 11alpha-oxido-17beta-hydroxy-17alpha-methyl-4-androstene-3-one and 9alpha, 11alpha-oxido-17beta-hydroxy-17alpha-methyl-1, 4-androstadiene-3-one were obtained. These microbiologically transformed products could be used as reference compounds in the enzyme assay. 相似文献
16.
The synthesis of the new progestogen, 17 alpha-ethinyl-17 beta-hydroxy-18-methyl-4,15-estradien-3-one (gestodene, 6), starting from 18-methyl-4-estren-3,17-dione (1) can be accomplished by several methods. The oral progestational activity of gestodene is greater than that of levonorgestrel. Gestodene, in combination with ethinylestradiol, is contained in a recently developed oral contraceptive. 相似文献
17.
The presence of androgen receptor (AR) in prostate cancer has been linked to the androgen-dependent nature of the tumor and has also been shown to have prognostic significance; it also appears to be a positive prognostic indicator in breast cancer. However, due to the relatively low AR concentrations in most tumors and the inherently low specific activity of tritium, the assay of AR based on available 3H-ligands is not sensitive enough to measure accurately the amount of receptor in small specimens. A 125I-ligand like those available for the estrogen and progesterone receptors would be helpful, but development of such a ligand for AR has not been very successful. Although several androgen analogues containing iodine, bromine, or selenium have been synthesized specifically as potential probes for AR, none have shown any significant affinity or specificity for the receptor. We therefore undertook the synthesis of new potential AR ligands which could be radioiodinated, and determined their affinities for AR (from rat uterus and MCF-7 human breast cancer cells) by using a competition assay. We have examined both 5 alpha-dihydrotestosterone (5 alpha-DHT) and 19-nortestosterone analogues and have identified two such compounds which showed high AR affinity: (17 alpha,20E)-17 beta-hydroxy-21-iodo-5 alpha-pregn-20-en-3-one (17 alpha-[E)-iodovinyl)-5 alpha-DHT, 9) and 17 beta-hydroxy-7 alpha-methyl-(17 alpha,20E)-21-iodo-19-norpregna-4,20-dien-3- one (7 alpha-methyl-17 alpha-[E)-iodovinyl)-19-nortestosterone, 11). In fact, the affinity of the latter for human AR was found to be superior to that of 5 alpha-DHT itself. These iodovinyl analogues could be easily prepared in the radioiodinated form, and should prove to be extremely useful in assaying low levels of AR in small specimens. 相似文献
18.
The inactivation of human placental aromatase by 17 alpha-ethynyl-10 beta-hydroperoxy-17 beta-hydroxy-4-estren-3-one (SCH 10015) was investigated. In either the presence or absence of added NADPH, SCH 10015 (Ki = 41 microM) caused a time-dependent loss of aromatase activity (e.g. 50% loss after 20 min with 20 microM SCH 10015). Evidence for the oxidation of an active site sulfhydryl group as the molecular basis for SCH 10015 inactivation is presented. The contraceptive 17 alpha-ethynyl-substituted 19-nor steroids, norethisterone (Ki = 48 microM) and norethynodrel (Ki = 38 microM), were evaluated and found not to inactivate aromatase, suggesting that the potential conversion of either compound to SCH 10015 did not occur to a significant extent in these microsomal incubations. It is speculated that the previously observed potent contraceptive effects of SCH 10015 may have been the result of irreversible inhibition of estrogen biosynthesis. 相似文献
19.
J F Templeton C C Jackson J W Steele 《European journal of drug metabolism and pharmacokinetics》1984,9(3):229-233
Methandrostenolone and the fully reduced metabolites 17 alpha-methyl-5 alpha-androstane-3 beta, 17 beta-diol and 17 alpha-methyl-5 beta-androstane-3 alpha, 17 beta-diol, the partially reduced and hydroxylated metabolites 16 alpha, 17 beta-dihydroxy-17 alpha-methyl-5 beta-androst-1-en-3-one and 16 beta, 17 beta-dihydroxy-17 alpha-methyl-5 beta-androst-1-en-3-one, the monohydroxylated metabolites 6 beta, 17 beta-dihydroxy-17 alpha-methyl-1,4-androstadien-3-one and 16 beta, 17 beta-dihydroxy-17 alpha-methyl-1,4-androstadien-3-one, and the dihydroxylated metabolite 6 beta, 16 beta, 17 beta-trihydroxy-17 beta-trihydroxy-17 alpha-methyl-1,4-androstadien-3-one have been isolated and identified in the urine of rabbits orally dosed with methandrostenolone. C-16 Hydroxylated and dihydroxylated metabolites have not been previously reported from methandrostenolone. No evidence for epimerization at the C-17 position was observed in the rabbit. 相似文献
20.
《Medicamentos de actualidad. Drugs of today》1968,4(1):7-9
The chemical profile of dimethisterone is presented. Dimethisterone (6alpha, 21-dimethylethisterone. 6 alpha, 21-dimethyl-17alpha-ethynyltestosterone. 17beta-hydroxy-6alpha-methyl-1 7-(1-propynyl)-androst-4-en-3-one) is a white crystalline powder that is soluble in ethanol, chloroform, and acetone, but not in water. The hydrated form of the drug melts at 103-113 degrees, while the anhydrous form melts at 137-139 degrees. The ultraviolet spectrum of dimethisterone in methanol shows a maximum at 242 mmc. A colorimetric assay has been developed on the basis of the reaction of dimethisterone with sulfuric acid to form a chromogenic substance absorbing at 490 mmc. 相似文献